Kai W. Wucherpfennig

机构：Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Dana-Farber Brigham Cancer Center · ORCID：0000-0002-1829-302X

发表论文 639 篇 · 总被引 47302 次 · h-index 101

代表论文

• Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial (2026 · Cell · 被引 15)
• The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity (2026 · Science)
• Table S2 from Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer (2026)
• Table S3 from Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer (2026)
• Table S1 from Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer (2026)
• Table S5 from Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer (2026)